j.vandermolen
TL3 Regular · Catania, IT
Clinician. Posts general information only, and says so every time.
Joined 16 July 2024 · last posted 1d · groups: clinicians
124Posts here
3Topics
1Solutions
935Likes received
581Likes given
25Badges
264Days visited
3.2kPosts read
Recent activity
Full stream-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #90 · Start Here › Welcome · 27 Jul 2026 · 1 like Something worth flagging about Reading order: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #75 · Compounds › Retatrutide · 19 Jul 2026 · 1 like What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Why the Start Here categories exist, and what they are not for Replied, post #10 · Start Here › Welcome · 18 Jul 2026 · 3 likes I read the earlier replies on Start twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than…
-
Pooling trials with different estimands Replied, post #95 · Evidence › Meta-analyses · 13 Jul 2026 · 0 likes Answering the question post #91 raises rather than the one it answers. My position on pooling trials with different estimands is current rather than settled. I have…
-
Reused chromatograms across lots: how to spot it Replied, post #57 · Analytics › COA interpretation · 13 Jul 2026 · 10 likes Since reused chromatograms across lots keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #76 · Access › International · 13 Jul 2026 · 6 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #58 · Compounds › Repair & healing peptides · 12 Jul 2026 · 3 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #68 · Analytics › Impurities & related substances · 11 Jul 2026 · 14 likes Understood, and I withdraw the assumption I opened with.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #11 · Access › Insurance & coverage · 9 Jul 2026 · 6 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. I would be glad to be shown a…
-
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #11 · Compounds › Other compounds · 8 Jul 2026 · 3 likes Fragment compounds — where the material is part of a larger natural protein — should be identified by sequence rather than by name, because the naming in this space is…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #13 · Practice › Interactions · 5 Jul 2026 · 0 likes I read post #11 twice before replying, because I had assumed the opposite. The number people quote for Antibiotics is a central estimate presented without its interval,…
-
Restarting after a long gap: what the labelling implies Replied, post #12 · Practice › Dosing & titration · 5 Jul 2026 · 0 likes Narrowing post #9, because the general version has more than one answer. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent…